61397-61-3

Usage

Uses

Due to the limited information available on CIS-2-(2,4-Dichlorophenyl)-2-(1H-imidazole-1-yl)methyl-4-(methanesulfonyloxy)methyl-1,3-dioxolane, its applications are currently not well-defined. However, given its complex structure and the presence of various functional groups, it may have potential uses in the following areas:
Used in Pharmaceutical Industry:
CIS-2-(2,4-Dichlorophenyl)-2-(1H-imidazole-1-yl)methyl-4-(methanesulfonyloxy)methyl-1,3-dioxolane could be used as a chemical intermediate or a building block for the synthesis of pharmaceutical compounds. Its imidazole and phenyl rings may offer opportunities for the development of new drugs with potential therapeutic applications.
Used in Chemical Research:
As a complex organic molecule, CIS-2-(2,4-Dichlorophenyl)-2-(1H-imidazole-1-yl)methyl-4-(methanesulfonyloxy)methyl-1,3-dioxolane may serve as a subject of study in chemical research. Its synthesis, reactivity, and potential transformations could be explored to understand its properties and identify possible applications in various fields.
Used in Material Science:
CIS-2-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOLE-1-YL)METHYL-4-(METHANE SULFONYLOXY)METHYL-1,3-DIOXALANE's unique structure may also make it a candidate for material science applications. Its potential use in the development of new materials with specific properties, such as improved stability or reactivity, could be investigated through further research.

InChI:InChI=1/C15H16Cl2N2O5S/c1-25(20,21)23-8-12-7-22-15(24-12,9-19-5-4-18-10-19)13-3-2-11(16)6-14(13)17/h2-6,10,12H,7-9H2,1H3/t12-,15+/m0/s1

Upstream product

• 61397-58-8 cis-2-(2,4-Dichlorophenyl)-2-[(1H-imidazol-1-yl)methyl]-1,3-dioxolane-4-methanol 
• 124-63-0 methanesulfonyl chloride 
• 83086-42-4 Benzoic acid (2R,4S)-2-(2,4-dichloro-phenyl)-2-imidazol-1-ylmethyl-[1,3]dioxolan-4-ylmethyl ester; compound with nitric acid 
• 61397-58-8 trans-2-(2,4-Dichlorophenyl)-2-<(1H-imidazol-1-yl)methyl>-1,3-dioxolane-4-methanol 
• 83086-42-4 Benzoic acid (2R,4R)-2-(2,4-dichloro-phenyl)-2-imidazol-1-ylmethyl-[1,3]dioxolan-4-ylmethyl ester; compound with nitric acid 

Downstream Products

• 83086-53-7 cis-<2-(2,4-dichlorophenyl)-2-<(1H-imidazol-1-yl)methyl>-1,3-dioxolan-4-yl>methyl thioacetate 
• 59363-98-3 1-[(2R,4S)-2-(2,4-Dichloro-phenyl)-4-phenoxymethyl-[1,3]dioxolan-2-ylmethyl]-1H-imidazole 
• 65277-42-1 ketoconazole 
• 67914-70-9 1-Formyl-4-<4-<-1,3-dioxolan-4-yl>methylenoxy>phenyl>piperazine 
• 150916-73-7 1-<3-methylbenzoxazol-2(3H)-on-6-yl>-4-<4-<methyleneoxy>phenyl>piperazine 
• 150916-79-3 1-<3-methylbenzthiazol-2(3H)-on-6-yl>-4-<4-<methyleneoxy>phenyl>piperazine 
• 150916-80-6 1-<1,3-dimethyl-benzimidazol-2(3H)-on-5-yl>-4-<4-<methyleneoxy>phenyl>piperazine 
• 65277-42-1 trans-Ketoconazole 
• 67915-53-1 1-Methanesulfonyl-4-<4-<-1,3-dioxolan-4-yl>methylenoxy>phenyl>piperazine 
• 149491-01-0 cis-2-(2,4-dichlorophenyl)-2-<(1H-imidazol-1-yl)methyl>-4-(mercaptomethyl)-1,3-dioxolane 
• 89848-36-2 2-Butyl-4-[4-(4-{4-[(2R,4S)-2-(2,4-dichloro-phenyl)-2-imidazol-1-ylmethyl-[1,3]dioxolan-4-ylmethoxy]-phenyl}-piperazin-1-yl)-phenyl]-5-methyl-2,4-dihydro-[1,2,4]triazol-3-one 
• 89848-38-4 4-[4-(4-{4-[(2R,4S)-2-(2,4-Dichloro-phenyl)-2-imidazol-1-ylmethyl-[1,3]dioxolan-4-ylmethoxy]-phenyl}-piperazin-1-yl)-phenyl]-2-isobutyl-5-methyl-2,4-dihydro-[1,2,4]triazol-3-one 
• 89848-35-1 2-Butyl-4-[4-(4-{4-[(2R,4S)-2-(2,4-dichloro-phenyl)-2-imidazol-1-ylmethyl-[1,3]dioxolan-4-ylmethoxy]-phenyl}-piperazin-1-yl)-phenyl]-2,4-dihydro-[1,2,4]triazol-3-one 
• 89848-34-0 4-[4-(4-{4-[(2R,4S)-2-(2,4-Dichloro-phenyl)-2-imidazol-1-ylmethyl-[1,3]dioxolan-4-ylmethoxy]-phenyl}-piperazin-1-yl)-phenyl]-2-isopropyl-5-methyl-2,4-dihydro-[1,2,4]triazol-3-one 

Relevant academic research and scientific papers

Synthesis and 13C NMR Spectra of cis- and trans-methyl>>-1,3-dioxolane-4-methanols

Syntheses and 13C nmr spectra of a number of cis and trans 2-(haloaryl)-2--4-(hydroxymethyl)-1,3-dioxolanes are described.The haloaryl groups are 2,4-dichloro, 2,4-difluoro-, 4-chloro- and 4-bromophenyl.In these series, some of the cis compounds become available through crystalline bromo benzoates 5.Separations of some trans isomers are achieved through fractional crystallizations of imidazolyl benzoate nitrates 6.Stereochemical assignments are based primarily on one major 13C chemical shift difference, namely that of C-4 of the 1,3-dioxolane ring, the chemical shift of the trans isomers being 1.0-2.5 ppm downfield from that of the cis isomers.